NEW YORK – After receiving 510 (k) clearance early this month from the US Food and Drug Administration for its sepsis test, Swiss diagnostics company Abionic is targeting the US for further ...
According to Research by SNS Insider, Host Cell Protein Testing Market Growth is Driven by Rising Demand for Biologics, Biosimilars, and Advanced Drug Development TechnologiesAustin, Oct. 22, 2024 ...
A new research paper was published in Oncotarget's Volume 15 on October 1, 2024, entitled, "Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition." ...